<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26336587</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1976-9148</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Biomolecules &amp; therapeutics</Title><ISOAbbreviation>Biomol Ther (Seoul)</ISOAbbreviation></Journal><ArticleTitle>Antiviral Activity of Chrysin Derivatives against Coxsackievirus B3 in vitro and in vivo.</ArticleTitle><Pagination><StartPage>465</StartPage><EndPage>470</EndPage><MedlinePgn>465-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4062/biomolther.2015.095</ELocationID><Abstract><AbstractText>Chrysin is a 5,7-dihydroxyflavone and was recently shown to potently inhibit enterovirus 71 (EV71) by suppressing viral 3C protease (3C(pro)) activity. In the current study, we investigated whether chrysin also shows antiviral activity against coxsackievirus B3 (CVB3), which belongs to the same genus (Enterovirus) as EV71, and assessed its ability to prevent the resulting acute pancreatitis and myocarditis. We found that chrysin showed antiviral activity against CVB3 at 10 &#x3bc;M, but exhibited mild cellular cytotoxicity at 50 &#x3bc;M, prompting us to synthesize derivatives of chrysin to increase the antiviral activity and reduce its cytotoxicity. Among four 4-substituted benzyl derivatives derived from C(5) benzyl-protected derivatives 7, 9-11 had significant antiviral activity and showed the most potent activity against CVB3 with low cytotoxicity in Vero cells. Intraperitoneal injection of CVB3 in BALB/c mice with 1&#xd7;10(6) TCID50 (50% tissue culture infective dose) of CVB3 induced acute pancreatitis with ablation of acinar cells and increased serum CXCL1 levels, whereas the daily administration of 9 for 5 days significantly alleviated the pancreatic inflammation and reduced the elevation in serum CXCL1 levels. Collectively, we assessed the anti-CVB3 activities of chrysin and its derivatives, and found that among 4-substituted benzyl derivatives, 9 exhibited the highest activity against CVB3 in vivo, and protected mice from CVB3-induced pancreatic damage, simultaneously lowering serum CXCL1 levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jae-Hyoung</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Bo-Eun</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Hongjun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Ajou University, Suwon 443-749.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Hyunju</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon 363-883.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sungchan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon 363-883.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kwisung</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Chungcheongnam-Do Institute of Health and Environmental Research, Daejeon 300-801, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Hyun-Jeong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyoungsu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Ajou University, Suwon 443-749.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Biomol Ther (Seoul)</MedlineTA><NlmUniqueID>101472832</NlmUniqueID><ISSNLinking>1976-9148</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral activity</Keyword><Keyword MajorTopicYN="N">Chrysin</Keyword><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">Flavonoid</Keyword><Keyword MajorTopicYN="N">Pancreatitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26336587</ArticleId><ArticleId IdType="pmc">PMC4556207</ArticleId><ArticleId IdType="doi">10.4062/biomolther.2015.095</ArticleId><ArticleId IdType="pii">bt-23-465</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alirezaei M, Flynn CT, Wood MR, Whitton JL. Pancreatic acinar cell-specific autophagy disruption reduces coxsackievirus replication and pathogenesis in vivo. Cell Host Microbe. 2012;11:298&#x2013;305. doi: 10.1016/j.chom.2012.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.01.014</ArticleId><ArticleId IdType="pmc">PMC3308121</ArticleId><ArticleId IdType="pubmed">22423969</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek SH, Jang H, Kim H. Synthesis and biological evaluation of acetylcholinesterase inhibitor macakurzin C and its derivatives. Synlett. 2015;26:1131&#x2013;1134. doi: 10.1055/s-0034-1380193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1380193</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke SJ, Lu D, Sparer TE, Masi T, Goff MR, Karlstad MD, Collier JJ. NF-kappaB and STAT1 control CXCL1 and CXCL2 gene transcription. Am J Physiol Endocrinol Metab. 2014;306:E131&#x2013;149. doi: 10.1152/ajpendo.00347.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00347.2013</ArticleId><ArticleId IdType="pmc">PMC3920007</ArticleId><ArticleId IdType="pubmed">24280128</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeckel E, Manns M, Von Herrath M. Viruses and diabetes. Ann N Y Acad Sci. 2002;958:7&#x2013;25. doi: 10.1111/j.1749-6632.2002.tb02943.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2002.tb02943.x</ArticleId><ArticleId IdType="pubmed">12021080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Alirezaei M, Flynn CT, Wood MR, Harkins S, Kiosses WB, Whitton JL. Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo. J Virol. 2010;84:12110&#x2013;12124. doi: 10.1128/JVI.01417-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01417-10</ArticleId><ArticleId IdType="pmc">PMC2976412</ArticleId><ArticleId IdType="pubmed">20861268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Lim D, Shin I, Lee D. Gram-scale synthesis of anti-pancreatic flavonoids (&#xb1;)-8-[1-(4&#x2032;-hydroxy-3&#x2032; methoxyphenyl) prop-2-en-1-yl]-chrysin and -galangin. Tetrahedron. 2014;70:4738&#x2013;4744. doi: 10.1016/j.tet.2014.05.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tet.2014.05.057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013;2013:162750. doi: 10.1155/2013/162750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/162750</ArticleId><ArticleId IdType="pmc">PMC3891543</ArticleId><ArticleId IdType="pubmed">24470791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, Shin I, Ko E, Lee K, Seo SY, Kim H. Total synthesis of acetylcholinesterase inhibitor macakurzin C. Synlett. 2014a;25:2794&#x2013;2796. doi: 10.1055/s-0034-1378904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1378904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PJ, Shin I, Seo SY, Kim H, Kim HP. Up-regulation of both heme oxygenase-1 and ATPase inhibitory factor 1 renders tumoricidal activity by synthetic flavonoids via depleting cellular ATP. Bioorg Med Chem Lett. 2014b;24:4845&#x2013;4849. doi: 10.1016/j.bmcl.2014.08.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2014.08.055</ArticleId><ArticleId IdType="pubmed">25223958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Kim SH, Kim Y, Lim Y, Ha K, Shin SY. Inhibitory effect of the antidepressant imipramine on NF-kappaB-dependent CXCL1 expression in TNFalpha-exposed astrocytes. Int Immunopharmacol. 2012;12:547&#x2013;555. doi: 10.1016/j.intimp.2012.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2012.01.011</ArticleId><ArticleId IdType="pubmed">22326584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren M, Darnerud PO, Blomberg J, Friman G, Ilback NG. Sequential changes in serum cytokines reflect viral RNA kinetics in target organs of a coxsackievirus B infection in mice. J Clin Immunol. 2009;29:611&#x2013;619. doi: 10.1007/s10875-009-9294-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-009-9294-8</ArticleId><ArticleId IdType="pubmed">19430896</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Kim DS, Cho YJ, Kim YJ, Jeong SY, Lee SM, Cho SJ, Yun CW, Jo I, Nam JH. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis. Vaccine. 2009;27:1974&#x2013;1983. doi: 10.1016/j.vaccine.2009.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.01.008</ArticleId><ArticleId IdType="pubmed">19168108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsingh AI. Coxsackieviruses and pancreatitis. Front Biosci. 1997;2:e53&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9257948</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnitzler P, Neuner A, Nolkemper S, Zundel C, Nowack H, Sensch KH, Reichling J. Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother. Res. 2010;24(Suppl 1):S20&#x2013;28. doi: 10.1002/ptr.2868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.2868</ArticleId><ArticleId IdType="pubmed">19472427</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Yeo SG, Hong EH, Lee BR, Kim JW, Kim J, Jeong H, Kwon Y, Kim H, Lee S, Park JH, Ko HJ. Antiviral activity of hederasaponin B from hedera helix against enterovirus 71 subgenotypes C3 and C4a. Biomol Ther. 2014;22:41&#x2013;46. doi: 10.4062/biomolther.2013.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2013.108</ArticleId><ArticleId IdType="pmc">PMC3936428</ArticleId><ArticleId IdType="pubmed">24596620</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol. 2000;62:70&#x2013;81. doi: 10.1002/1096-9071(200009)62:1&lt;70::AID-JMV11&gt;3.0.CO;2-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200009)62:1&lt;70::AID-JMV11&gt;3.0.CO;2-R</ArticleId><ArticleId IdType="pubmed">10935991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang T, Du J, Cui S, Yang F, Jin Q. Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS One. 2014;9:e89668. doi: 10.1371/journal.pone.0089668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089668</ArticleId><ArticleId IdType="pmc">PMC3943725</ArticleId><ArticleId IdType="pubmed">24598537</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilsky S, Sobotta K, Wiesener N, Pilas J, Althof N, Munder T, Wutzler P, Henke A. Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication. Arch Virol. 2012;157:259&#x2013;269. doi: 10.1007/s00705-011-1164-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1164-z</ArticleId><ArticleId IdType="pubmed">22075919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood LD, Farmer AA, Richmond A. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res. 1995;23:4210&#x2013;4219. doi: 10.1093/nar/23.20.4210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/23.20.4210</ArticleId><ArticleId IdType="pmc">PMC307364</ArticleId><ArticleId IdType="pubmed">7479086</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009;119:2615&#x2013;2624. doi: 10.1161/CIRCULATIONAHA.108.766022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.766022</ArticleId><ArticleId IdType="pubmed">19451363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin D, Li J, Lei X, Liu Y, Yang Z, Chen K. Antiviral activity of total flavonoid extracts from selaginella moellendorffii hieron against coxsackie virus B3 in vitro and in vivo. Evid Based Complement Alternat Med. 2014;2014:950817. doi: 10.1155/2014/950817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/950817</ArticleId><ArticleId IdType="pmc">PMC4055240</ArticleId><ArticleId IdType="pubmed">24963331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragoza C, Saura M, Padalko EY, Lopez-Rivera E, Lizarbe TR, Lamas S, Lowenstein CJ. Viral protease cleavage of inhibitor of kappaBalpha triggers host cell apoptosis. Proc Natl Acad Sci USA. 2006;103:19051&#x2013;19056. doi: 10.1073/pnas.0606019103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606019103</ArticleId><ArticleId IdType="pmc">PMC1748175</ArticleId><ArticleId IdType="pubmed">17138672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HM, Ye X, Su Y, Yuan J, Liu Z, Stein DA, Yang D. Coxsackievirus B3 infection activates the unfolded protein response and induces apoptosis through downregulation of p58IPK and activation of CHOP and SREBP1. J Virol. 2010;84:8446&#x2013;8459. doi: 10.1128/JVI.01416-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01416-09</ArticleId><ArticleId IdType="pmc">PMC2918999</ArticleId><ArticleId IdType="pubmed">20554776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Zhang Y, Ye G, Li Z, Zhou P, Huang C. In vivo and in vitro antiviral activities of calycosin-7-O-beta-D-glucopyranoside against coxsackie virus B3. Biol Pharm Bull. 2009;32:68&#x2013;73. doi: 10.1248/bpb.32.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.32.68</ArticleId><ArticleId IdType="pubmed">19122283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>